Taylor Diagnostic Imaging INC

Taylor Diagnostic Imaging INC was paid $1.85M by Medicaid between Jun 2021 and Oct 2023, across 15 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 64% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Michigan

Rank by total paid#27 of 108

Median peer was paid$588K

This provider vs. median3.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	13,887	$567K
2022	25,356	$1.12M
2023	2,216	$166K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	64%	19,229	16,592	$1.18M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	20%	18,147	15,627	$371K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	11%	1,745	1,683	$204K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	1.5%	122	118	$28K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	1.5%	821	745	$27K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	118	116	$8K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	226	205	$8K
87634		<1%	118	116	$6K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	152	150	$6K
87486		<1%	204	199	$4K
87581		<1%	204	199	$3K
87631		<1%	26	26	$2K

3 more codes

87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	184	$2K
86769		<1%	37	$1K
K1034	Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count	<1%	126	$572.16

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBUCK, DOMINIQUE (PRESIDENT)

Parent organizationTAYLOR DIAGNOSTIC IMAGING INC